[{"label": "0", "tokenized": "glaxo wellcom plc today releas new data indic it drug zeffix may help prevent chronic hepat suffer from develop cirrhosi", "origin": "Glaxo Wellcome PLC today released new data indicating its drug Zeffix may help prevent chronic hepatitis B sufferers from developing cirrhosis"}, {"label": "0", "tokenized": "the data from three larg clinic studi show smaller proport of chronic hepat patient treat with zeffix progress to cirrhosi , or liver scar , compar with those treat with placebo or interferon alpha", "origin": "The data from three large clinical studies showed a smaller proportion of chronic hepatitis B patients treated with Zeffix progressed to cirrhosis, or liver scarring, compared with those treated with placebo or interferon alpha"}, {"label": "0", "tokenized": "the result were present at the annual meet of the european associ for the studi of the liver in napl , and support by other data show addit zeffix benefit , glaxo said", "origin": "The results were presented at the annual meeting of the European Association for the Study of the Liver in Naples, and supported by other data showing additional Zeffix benefits, Glaxo said"}, {"label": "0", "tokenized": "onli 18 percent of zeffix treat patient progress to cirrhosi , compar with 71 percent placebo treat patient and 95 percent of those treat with interferon alpha", "origin": "Only 18 percent of Zeffix treated patients progressed to cirrhosis, compared with 71 percent placebo treated patients and 95 percent of those treated with interferon alpha"}, {"label": "0", "tokenized": "glaxo said the result show continu increas in the incid of antigen seroconvers an immun respons to the viru that is thought to predict long last remiss of the diseas and continu reduct in level of viral replic", "origin": "Glaxo said the results showed a continued increase in the incidence of e antigen seroconversion    an immune response to the virus that is thought to predict long lasting remission of the disease    and a continued reduction in levels of viral replication"}, {"label": "0", "tokenized": "zeffix is avail in the philippin , canada and the us and approv in china , hong kong , thailand , pakistan and new zealand", "origin": "Zeffix is available in the Philippines, Canada and the US and approved in China, Hong Kong, Thailand, Pakistan and New Zealand"}, {"label": "0", "tokenized": "regulatori applic have been made in korea , taiwan , japan and europ", "origin": "Regulatory applications have been made in Korea, Taiwan, Japan and Europe"}, {"label": "0", "tokenized": "hepat is potenti fatal liver diseas the ninth most common killer worldwid", "origin": "Hepatitis B is a potentially fatal liver disease    the ninth most common killer worldwide"}, {"label": "0", "tokenized": "about 350 million peopl are long term carrier of the hepat viru and nearli one third are expect to develop progress inflamm of the liver , lead to cirrhosi and liver cancer", "origin": "About 350 million people are long term carriers of the hepatitis B virus and nearly one third are expected to develop progressive inflammation of the liver, leading to cirrhosis and liver cancer"}, {"label": "0", "tokenized": "previous , therapi for chronic hepat were limit to interferon , which are inject and can lead to unpleas side effect", "origin": "Previously, therapies for chronic hepatitis B were limited to interferons, which are injected and can lead to unpleasant side effects"}]